294090 · KOSDAQ · ₩294090 · 이오플로우
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range0.0% from the high
₩1,490Today: ₩1,490 – ₩1,490₩1,490
Returns
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals describe activity, not recommendations. Not financial advice.
EOFlow (이오플로우, KRX: 294090) is listed on KOSDAQ, in the Medical & precision devices sector. The company is a Korean medical device manufacturer founded in 2011 that supplies wearable drug delivery solutions based on its electro-osmotic pump technology. Its shares closed at ₩1,490 on Oct 27, 2026, unchanged on the day, giving it a market value of ₩75B.
The company is a Korean medical device manufacturer founded in 2011 that supplies wearable drug delivery solutions based on its electro-osmotic pump technology. Its main product is EOPatch, a disposable wearable insulin pump that is attached to the body without tubing and controlled by a separate controller or a smartphone app, with sales in South Korea and Europe. The company is also developing non-insulin drug delivery systems for pharmaceutical partners and related medical fields.
Written by AI from the company's latest annual report.
Predicted impact: Medium
Favorable US litigation ruling, but earlier lawsuit news and convertible issuance already reported; restructuring still uncertain.
Predicted impact: Medium
Same US lawsuit advantage already reported recently; restructuring uncertainty is a meaningful but repeated concern.
Predicted impact: Medium· Actual: −0.8% vs sector (5 trading days)
₩10B convertible bonds are about 16% of ₩62B market value; listing review issue adds concern.
Titles in Korean until English translations are added.
Also known as: EOFlow / 이오플로우 / 294090 / KRX:294090
Source: KRX statistical information